Treace Medical Concepts Inc Net Assets
Treace Medical Concepts Inc net assets. Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has net assets worth $77.19 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($184.10 Million) and total liabilities ($106.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Treace Medical Concepts Inc (TMCI) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $77.19 Million |
| % of Total Assets | 41.93% |
| Annual Growth Rate | 73.85% |
| 5-Year Change | -6.17% |
| 10-Year Change | N/A |
| Growth Volatility | 4434.8 |
Net Assets of Treace Medical Concepts Inc (2019–2025)
Net assets of Treace Medical Concepts Inc from 2019 to 2025. This chart illustrates how Treace Medical Concepts Inc's net assets have evolved over time, based on quarterly financial data. See TMCI net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual net assets of Treace Medical Concepts Inc from 2019 to 2025. For live market cap and overall valuation, see Treace Medical Concepts Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $87.33 Million | -22.64% |
| 2024-12-31 | $112.89 Million | -18.16% |
| 2023-12-31 | $137.94 Million | +127.89% |
| 2022-12-31 | $60.53 Million | -34.97% |
| 2021-12-31 | $93.07 Million | +11893.94% |
| 2020-12-31 | $776.00K | -75.45% |
| 2019-12-31 | $3.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Treace Medical Concepts Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 23130600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Treace Medical Concepts Inc Net Assets Breakdown (December 2025)
Treace Medical Concepts Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $64.00K | 0.07% |
| Other Comprehensive Income | $72.00K | 0.08% |
| Other Components | $336.19 Million | 384.95% |
| Total Equity | $87.33 Million | 100.00% |
Treace Medical Concepts Inc Competitors by Market Cap
The table below lists competitors of Treace Medical Concepts Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NexG Bhd
KLSE:5216
|
$227.76 Million |
|
Síminn hf
IC:SIMINN
|
$227.80 Million |
|
Martifer SGPS S.A
LS:MAR
|
$227.84 Million |
|
Comefly Outdoor Co Ltd
SHG:603908
|
$227.85 Million |
|
Dongsung FineTec Co. Ltd
KQ:033500
|
$227.67 Million |
|
Asia Cuanon Tech (Shanghai)
SHG:603378
|
$227.66 Million |
|
centrotherm international AG
F:CTNK
|
$227.62 Million |
|
Tanvex BioPharma Inc
TW:6541
|
$227.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Treace Medical Concepts Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 112,892,000 to 87,332,000, a change of -25,560,000 (-22.6%).
- Net loss of 59,002,000 reduced equity.
- Other comprehensive income decreased equity by 25,000.
- Other factors increased equity by 33,467,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-59.00 Million | -67.56% |
| Other Comprehensive Income | $-25.00K | -0.03% |
| Other Changes | $33.47 Million | +38.32% |
| Total Change | $- | -22.64% |
Book Value vs Market Value Analysis
This analysis compares Treace Medical Concepts Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.10x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 69.28x to 3.10x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.06 | $4.28 | x |
| 2020-12-31 | $0.02 | $4.28 | x |
| 2021-12-31 | $1.72 | $4.28 | x |
| 2022-12-31 | $1.10 | $4.28 | x |
| 2023-12-31 | $2.27 | $4.28 | x |
| 2024-12-31 | $1.82 | $4.28 | x |
| 2025-12-31 | $1.38 | $4.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Treace Medical Concepts Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.74%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 2.18x
- Recent ROE (-67.56%) is above the historical average (-121.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -134.93% | -10.82% | 1.33x | 9.40x | $-4.58 Million |
| 2020 | -472.68% | -6.39% | 1.37x | 53.88x | $-3.75 Million |
| 2021 | -22.08% | -21.77% | 0.67x | 1.51x | $-29.86 Million |
| 2022 | -70.73% | -30.19% | 0.89x | 2.63x | $-48.87 Million |
| 2023 | -35.91% | -26.47% | 0.74x | 1.83x | $-63.32 Million |
| 2024 | -49.38% | -26.63% | 0.96x | 1.92x | $-67.03 Million |
| 2025 | -67.56% | -27.74% | 1.12x | 2.18x | $-67.74 Million |
Industry Comparison
This section compares Treace Medical Concepts Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $296,528,539
- Average return on equity (ROE) among peers: -35.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Treace Medical Concepts Inc (TMCI) | $77.19 Million | -134.93% | 1.39x | $227.70 Million |
| Abbott Laboratories (ABT) | $2.83 Billion | 34.08% | 0.96x | $190.23 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $2.34 Million |
| Aethlon Medical Inc (AEMD) | $-3.66 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-11.59 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $850.46 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $2.43 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $21.01K |
| Autonomix Medical, Inc. Common Stock (AMIX) | $5.89 Million | -283.55% | 0.29x | $1.61 Million |
| Artivion Inc (AORT) | $276.20 Million | -4.84% | 1.86x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $14.18 Million | 18.92% | 0.18x | $109.52 Million |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more